This study is testing Barrigel, an absorbable gel, to see if it can protect the rectum during radiation therapy for prostate cancer. If you're a man aged 18 or older who has had a radical prostatectomy (surgery to remove the prostate) for prostate cancer, you might be able to join. The study aims to reduce the amount of radiation the rectum receives by creating a space between the rectum and the prostate area. Researchers will measure this reduction after 3 months. The study is currently recruiting 84 participants, but its overall status is unclear.

Study design

This is a prospective, randomized, controlled, single-masked multicenter study involving 84 participants. Some participants will receive Barrigel, while others will have a sham procedure.

What's involved

You will undergo a transrectal ultrasound (TRUS) procedure. If you receive Barrigel, the TRUS will guide its placement.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome, reduction in rectal radiation dose, is measured at 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.